Annual Secretarial Compliance Report for the Financial Year 2025-26.
ROSSARI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Rossari Biotech Ltd has filed its Annual Secretarial Compliance Report for FY 2025-26, prepared by Practicing Company Secretaries M/s. Shah Patel & Associates. The report, submitted under SEBI Regulation 24A, covers compliance with multiple SEBI regulations including LODR 2015, ICDR 2018, SAST 2011, Share Based Employee Benefits Regulations 2021, PIT Regulations 2015, and Depositories Regulations 2018. All 13 compliance checkpoints assessed by the secretarial auditor returned a 'Yes' (compliant) status, with no deviations, fines, or observations noted. The auditor confirmed the company has proper Board processes, no disqualified directors, compliant related party transactions, timely disclosures under Regulation 30, and no SEBI or stock exchange actions taken against the entity. No additional non-compliances were observed.
Clean compliance report — no regulatory red flags. Signals strong corporate governance and adherence to SEBI norms for the review period, which is broadly positive for investor confidence.